Search results
MacroGenics to Participate in Upcoming Investor Conferences
Morningstar· 4 days agoROCKVILLE, MD, May 13, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal ...
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 4 days agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with...
Pipeline Moves: Phase III completion for Corcept’s relaorilant
Clinical Trials Arena via Yahoo Finance· 4 days agoAlso, Lyvgen’s monoclonal antibody (mAb) dalnicastobart has seen its transition prospects increase...
GSK to divest remaining 4.2% stake in Haleon
Pharmaceutical Technology via Yahoo Finance· 6 hours agoThe agreement comprises an upfront payment of $1bn and $400m in regulatory milestone payments. Through the deal, GSK will gain access to AIO-001, a...
Uniquity Bio launches to focus on immunology and inflammation
Pharmaceutical Technology via Yahoo Finance· 1 day agoA monoclonal antibody, solrikitug targets thymic stromal lymphopoietin. It will treat critical...
Sanofi to Spend $1.08 Billion to Boost Drug Production in France
Morningstar· 4 days agoSanofi will spend more than 1 billion euros ($1.08 billion) on ramping up production capability in France. The French pharmaceutical company said Monday that the bulk of the investment will ...
Adagene Inc. (NASDAQ:ADAG) Short Interest Up 6.3% in April
ETF DAILY NEWS· 11 hours agoAdagene Inc. (NASDAQ:ADAG – Get Free Report) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 15,100 shares, an increase ...
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
The Wall Street Journal· 7 days agoThe company’s trial was evaluating the cancer-drug Opdivo and concurrent chemoradiotherapy, followed...
Sanofi boosts French biomanufacturing with €1 billion investment
Investing.com· 4 days agoSanofi (EPA: SASY ) (NASDAQ: SNY ), a global biopharmaceutical company, announced today a...
Immunovant, Inc. (NASDAQ:IMVT) Short Interest Update
ETF DAILY NEWS· 12 hours agoImmunovant, Inc. (NASDAQ:IMVT – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totalling 8,960,000 shares, ...
